Canadian Journal of Anesthesia, Vol 41, 387-392, Copyright © 1994 by Canadian Anesthesiologists' Society

ARTICLES

Bupivacaine 0.125% improves continuous postoperative epidural fentanyl analgesia after abdominal or thoracic surgery

NH Badner, R Bhandari and WE Komar
Department of Anaesthesia, University Hospital, University of Western Ontario, London, Canada.

The addition of 0.125% and 0.25% bupivacaine to continuous postoperative epidural infusions of fentanyl, in a 10 micrograms.ml-1 concentration, were studied in 39 patients following abdominal or thoracic surgery in prospective, random, double-blind fashion. Patients received an initial bolus of 0.1 ml.kg-1 of the the study solution and an infusion of 6 ml.hr-1 which was titrated to maintain analgesia (VAS < 40). Assessments of pain (VAS), pulmonary function (pH, PaCO2), and bowel function (time to flatus or po fluids) were made until the second post-operative morning. There was a difference among the three groups in analgesia (means VAS scores) over time (P < 0.01), with the fentanyl-alone group producing less analgesia than the 0.125% bupivacaine group (P < 0.01). There was no difference in the average infusion rates, postoperative pulmonary function, or bowel function. The incidence of side effects including somnolence, nausea and vomiting, and pruritus was also similar. Fewer patients in the 0.125% bupivacaine group than in the 0.25% group developed a transient sensory loss to pinprick and ice (3 vs 10, P < 0.001). Four patients in both bupivacaine groups had leg weakness, those in the 0.125% were all a Bromage 1 score, while in the 0.25% group one had a Bromage 1, one a Bromage 2, and two Bromage 3 scores. The addition of 0.125% bupivacaine improves the analgesia of epidural infusions of fentanyl (10 microgms.ml(-1)) when used following abdominal or thoracic surgery and results in minimal sensorimotor disturbance.

This article has been cited by other articles:

				R. S. Sinatra MD, J. Torres, and A. M. Bustos Pain Management After Major Orthopaedic Surgery: Current Strategies and New Concepts J. Am. Acad. Ortho. Surg., March 1, 2002; 10(2): 117 - 129. [Abstract] [Full Text] [PDF]

				D. J. Kopacz, N. E. Sharrock, and H. W. Allen A Comparison of Levobupivacaine 0.125%, Fentanyl 4 {micro}g/mL, or Their Combination for Patient-Controlled Epidural Analgesia After Major Orthopedic Surgery Anesth. Analg., December 1, 1999; 89(6): 1497 - 1497. [Abstract] [Full Text] [PDF]

				E. Cohen Postthoracotomy Pain Management Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1999; 3(3): 156 - 167. [Abstract] [PDF]

				D. A. Scott, D. Blake, M. Buckland, R. Etches, R. Halliwell, C. Marsland, G. Merridew, D. Murphy, M. Paech, S. A. Schug, et al. A Comparison of Epidural Ropivacaine Infusion Alone and in Combination with 1, 2, and 4 {micro}g/mL Fentanyl for Seventy-Two Hours of Postoperative Analgesia After Major Abdominal Surgery Anesth. Analg., April 1, 1999; 88(4): 857 - 857. [Abstract] [Full Text] [PDF]